SCHEMBL13367392

SCHEMBL13367392

Cc1cc(C)cc(N(C)c2cc3ccccc3c3ccccc23)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.44
CYP2A6 P11509 2/20 0.44
TRPM4 Q8TD43 1/20 0.37
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 3/20 0.36
CYP1B1 Q16678 2/20 0.36
HIF1A Q16665 1/20 0.36
HPGD P15428 2/20 0.36
SIGMAR1 Q99720 3/20 0.35
HPRT1 P00492 1/20 0.34
CYP1A1 P04798 1/20 0.34
TSPO P30536 1/20 0.34
DHFR P00374 1/20 0.33
TSHR P16473 2/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13367461 0.87 SIGMAR1 (0.45) CYP1A2CYP2A6ALDH1A1HSD17B10HPGD
SCHEMBL12258281 0.86 CYP1A2 (0.40) CYP1A2CYP2A6TRPM4ALDH1A1HSD17B10
SCHEMBL6283489 0.84 CYP1A2 (0.46) CYP1A2CYP2A6TRPM4ALDH1A1HSD17B10
SCHEMBL12048720 0.84 TRPM4 (0.41) TRPM4ALDH1A1HSD17B10CYP1B1HIF1A
SCHEMBL12048243 0.82 CYP1A2 (0.37) CYP1A2CYP2A6TRPM4ALDH1A1HSD17B10
SCHEMBL13367470 0.80 CYP1A2 (0.51) CYP1A2CYP2A6TRPM4ALDH1A1HSD17B10
SCHEMBL12048256 0.80 CYP1A2 (0.35) CYP1A2CYP2A6ALDH1A1HPGDTSHR
SCHEMBL13338578 0.79 CYP1A2 (0.41) CYP1A2CYP2A6TRPM4ALDH1A1HSD17B10
SCHEMBL13367600 0.78 SLC6A2 (0.40) TRPM4ALDH1A1HSD17B10CYP1B1HIF1A
SCHEMBL18799896 0.78 CES2 (0.38) TRPM4ALDH1A1HSD17B10CYP1B1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 CYP1A2 1021/4885CYP2A6 2286/4885TRPM4 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.